KIMS Hospitals Expands Fertility Care with New IVF Center in Visakhapatnam

On 10 August 2026, KIMS Hospitals announced the launch of a specialist Fertility & IVF Center in Visakhapatnam, Andhra Pradesh, expanding its network of reproductive healthcare providers and bringing patients in the area closer to expert infertility treatment. With treatment options encompassing a wide spectrum of reproductive health requirements, the new facility is designed to meet the needs of couples seeking assisted reproductive care and fertility evaluation. IVF, IUI, ICSI, fertility preservation, donor programs, hormonal and genetic testing, fertility counseling, embryo transfer, blastocyst culture, and male fertility assessment are among the services offered by the center. KIMS extends access to fertility services outside major urban healthcare markets by opening a dedicated center in Visakhapatnam.

The center supports various stages of assisted reproduction by combining clinical fertility services with specialized laboratory and diagnostic capabilities. The COOKS MINC benchtop incubator, Voluson SWIGT imaging equipment, which offers 3D and 4D imaging with AI-assisted automation, and a Class 1000 IVF laboratory are all available at the KIMS Fertility Vizag facility. These skills can help with laboratory procedures related to assisted reproduction monitoring and fertility assessment. The advancement reflects the expanding significance of sophisticated infrastructure in the field of fertility care, where treatment is becoming more dependent on reproductive imaging, specialist embryology labs, and customized clinical evaluation.

By offering patients in Visakhapatnam and the surrounding areas specialized fertility services within the city, the new center is also anticipated to enhance regional access to reproductive healthcare. Instead of depending solely on fertility centers in larger cities, couples seeking assisted reproduction can get advice, diagnostic examinations, and several treatment options through a dedicated reproductive facility. Locations including Hyderabad, Visakhapatnam, Guntur, Kurnool, and Nagpur are already part of KIMS Fertility's larger network, underscoring the company's emphasis on expanding fertility services throughout several regional markets.

Impact on Healthcare Industry

By increasing access to advanced reproductive treatment in Visakhapatnam and surrounding areas, the launch is anticipated to bolster Andhra Pradesh's specialized healthcare sector. KIMS Fertility claims that the center combines laboratory tests, counseling, assisted reproductive techniques for diagnostics, and fertility advice. In addition to promoting the growth of local reproductive healthcare facilities, this can lessen the need for patients to travel to bigger cities for specialized fertility care. As modern reproductive medicine depends more on sophisticated imaging, regulated IVF labs, specialist embryology, and individualized treatment planning, the expansion also emphasizes the growing significance of technology-enabled fertility treatment. Fertility specialist embryologists' reproductive diagnostics and allied healthcare professions may become more in demand if established healthcare providers extend their fertility services into local markets.

Impact on the In-Vitro Fertilization Market

The global in-vitro fertilization market size was estimated at USD 32.11 billion in 2025 and is predicted to increase from USD 34.97 billion in 2026 to approximately USD 73.09 billion by 2035, expanding at a CAGR of 8.57% from 2026 to 2035.

According to Precedence Research, the IVF market is growing due to several variables, including diminishing fertility rates, rising infertility, older first-time mothers, and increased awareness of advanced infertility treatment. Asia Pacific is expected to grow at the quickest CAGR throughout the forecast period, while Europe held the greatest market share in 2024.

The opening of the Fertility & IVF Center at KIMS Hospitals in Visakhapatnam shows how IVF infrastructure is still growing throughout the Asia Pacific area. In regional cities, the provision of specialized fertility services can enhance patient access and encourage the broader use of assisted reproductive technologies. IVF, IUI, ICSI blastocyst transfer, and embryo cryopreservation are among the reproductive therapies that KIMS offers, allowing patients to choose from a variety of choices according to their expansion, which may lessen geographical obstacles to receiving specialized fertility care, especially for people who reside in and around Visakhapatnam.

The IVF market is also expected to be impacted by the increasing incorporation of cutting-edge technology. Artificial intelligence is being used more frequently in IVF operations, such as embryo evaluation and individualized treatment planning, according to preceding research. The IVF industry is anticipated to become more technology-driven as fertility clinics continue to invest in specialized labs, imaging systems, reproductive diagnostics, and cutting-edge embryo-related technologies. KIMS Hospitals' entry into Visakhapatnam contributes to the larger push for more easily available and cutting-edge reproductive care. Opportunities for increased use of cutting-edge laboratory technology and embryology techniques may also arise from the availability of specialized IVF infrastructure. It is anticipated that these advancements will bolster the entire fertility treatment ecosystem and motive medical professionals to increase their IVF capacity.

As specialists facilitate becoming more accessible throughout regional markets, growth can also lead to increased competition among fertility service providers. Increased competition may motivate providers to make investments in cutting-edge technologies, patient support services, and treatment infrastructure. Growing accessibility can also enable couples who may have had limited access to specialized fertility care to become more aware of assisted reproductive alternatives.

Impact on the Fertility Market

The global fertility market size was calculated at USD 39.27 billion in 2025 and is predicted to increase from USD 42.37 billion in 2026 to approximately USD 92.60 billion by 2035, expanding at a CAGR of 8.96% from 2026 to 2035.

According to Precedence Research, the assisted reproductive technology segment accounted for the largest offering share, while fertility clinics represented the largest end-user segment. The expanding demand for infertility treatment, growing awareness of reproductive technologies, and increasing availability of fertility services are expected to support continued market growth.

By making structured fertility services more accessible in Andhra Pradesh. KIMS Hospitals' expansion is anticipated to contribute to this rise. The center's emphasis on both male and female infertility as well as fertility assessment and assisted reproductive technologies. Genetic testing and fertility preservation represent the industry's shift away from IVF-only treatment and toward complete reproductive healthcare. Make infertility, ICSI, egg donation, embryo cryopreservation, and other reproductive treatments among the conditions and producers covered by KIMS fertility services. Instead of depending on a single treatment strategy, the broader range of services can assist individuals in receiving fertility assessment and therapy based on their unique circumstances.

As more people become aware of the alternatives for treatment, the development may also promote increased use of advanced reproductive techniques and fertility preservation. By processing embryo photos and assisting with embryo selection, AI is becoming increasingly important to fertility care. According to Precedence Research, it is projected that the combination of specialized medical knowledge, cutting-edge reproductive technology, and growing networks of fertility centers will enhance the accessibility of individualized fertility treatment and sustain growth in the global fertility industry. Fertility services are becoming more prevalent in regional locations, which can improve patient access and open new prospects for medical professionals. Additionally, it is anticipated to promote investments in laboratory infrastructure, specialist-led fertility services, and reproductive diagnostics.

The development of allied healthcare services such as genetic testing, reproductive counseling, fertility preservation, and male infertility management may also be aided by the growth of comprehensive fertility centers. Demand is anticipated to move toward a more comprehensive fertility care model that covers diagnosis, treatment, and long-term reproductive planning. As people become more aware of these possibilities, hospitals and specialist fertility providers may have more chances to establish integration. Reproductive healthcare networks because of this development.

About KIMS Hospitals

Krishna Institute of Medical Sciences Limited, also known as KIMS Hospitals, is a healthcare organization that provides specialized and multispecialty medical services throughout India. The business has been strengthening specialty care facilities, growing its geographic reach, and incorporating cutting-edge medical technology throughout its network. In addition to other specialized healthcare facilities and improvements, the FY 2024–2025 annual report announced the opening of a fertility center in Vizag.

The Institute of Reproductive Sciences and fertility centers KIMS provides specialized reproductive healthcare services, including IUI, OVF, ICSI blastocyst transfer, preimplantation genetic diagnosis, cryopreservation of eggs and embryos, and egg donations. In addition to counseling and patient support services. Its IVF services are backed by experts in reproductive endocrinology, reproductive urology, embryology, andrology, immunology, and gynecology. To provide complete fertility treatment, the organization integrates specialized medical knowledge with reproductive technologies and fertility laboratory skills.

In addition to supporting KIMS Hospitals' long-term goal of extending specialized and cutting-edge healthcare services throughout regional markets, the opening of the Fertility and IVF Centers in Visakhapatnam enhances the organization's reproductive healthcare presence in Andhra Pradesh. Patients in the area may have easier access to assisted reproductive procedures, diagnostic tests, and fertility consultations thanks to the centers. KIMS is also well positioned to meet the growing need for sophisticated infertility treatment and reproductive healthcare by growing its fertility networks.

The broader change occurring in India's healthcare industry, where specialized treatments are increasingly being paired with cutting-edge technologies and patient-focused care models, is reflected in KIMS Hospitals' entry into the fertility care market. The organization is bolstering its position in the fertility services market and advancing the development of easily accessible and technologically enabled reproductive healthcare in India through its expanding reproductive healthcare capabilities.